ES2139580T3 - Vitaleteina y su uso en el cultivo celular y en terapia. - Google Patents

Vitaleteina y su uso en el cultivo celular y en terapia.

Info

Publication number
ES2139580T3
ES2139580T3 ES91915854T ES91915854T ES2139580T3 ES 2139580 T3 ES2139580 T3 ES 2139580T3 ES 91915854 T ES91915854 T ES 91915854T ES 91915854 T ES91915854 T ES 91915854T ES 2139580 T3 ES2139580 T3 ES 2139580T3
Authority
ES
Spain
Prior art keywords
vitaletheine
therapy
cell culture
cell
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91915854T
Other languages
English (en)
Inventor
Galen Daryl Knight
Terence Joseph Scallen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of New Mexico UNM
Original Assignee
University of New Mexico UNM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of New Mexico UNM filed Critical University of New Mexico UNM
Application granted granted Critical
Publication of ES2139580T3 publication Critical patent/ES2139580T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0025—Culture media for plant cell or plant tissue culture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/40—Y being a hydrogen or a carbon atom
    • C07C323/41—Y being a hydrogen or an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C12N2500/33—Amino acids other than alpha-amino carboxylic acids, e.g. beta-amino acids, taurine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Botany (AREA)
  • Virology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

SE MUESTRAN DERIVADOS DE CARBOXI TIENEN AZUFRE NUEVOS, INCLUYENDO VITALETEINA, VITALETINA, VITALETEINA, V4. LOS DERIVADOS POSEEN UTILIDAD, ENTRE OTRAS COSAS, COMO SUPLEMENTOS DE MEDIO DE CULTIVO DE TEJIDO PARA MEJORAR LA EXPRESION FENOTIPICA CELULAR, LA FUNCION CELULAR, PRODUCCION CELULAR, Y VITALIDAD CELULAR, Y PARA LA PROFILAXIS O TRATAMIENTO DE ENFERMEDAD O DESORDEN INCLUYENDO NEOPLASIA.
ES91915854T 1990-07-06 1991-07-08 Vitaleteina y su uso en el cultivo celular y en terapia. Expired - Lifetime ES2139580T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54910590A 1990-07-06 1990-07-06
US54943890A 1990-07-06 1990-07-06
US54944090A 1990-07-06 1990-07-06

Publications (1)

Publication Number Publication Date
ES2139580T3 true ES2139580T3 (es) 2000-02-16

Family

ID=27415550

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91915854T Expired - Lifetime ES2139580T3 (es) 1990-07-06 1991-07-08 Vitaleteina y su uso en el cultivo celular y en terapia.

Country Status (10)

Country Link
EP (1) EP0539525B1 (es)
JP (1) JP3259960B2 (es)
AT (1) ATE186048T1 (es)
AU (1) AU655598B2 (es)
DE (1) DE69131752T2 (es)
DK (1) DK0539525T3 (es)
ES (1) ES2139580T3 (es)
GR (1) GR3031801T3 (es)
HK (1) HK1014367A1 (es)
WO (1) WO1992000955A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1018877A4 (en) * 1995-10-17 2000-08-09 Dovetail Technologies Inc LOW MOLECULAR WEIGHT STIMULANTS OF BONE MARROW AND IMMUNE SYSTEM CELLS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2495857B1 (fr) * 1980-08-27 1987-11-27 Petit Jean Filtre numerique recursif de surechantillonnage en arithmetique distribuee
US4552765A (en) * 1982-05-14 1985-11-12 Santen Pharmaceutical Co., Ltd. Aletheine derivatives
EP0538330B1 (en) * 1990-07-06 1995-10-11 University Of New Mexico Beta-alethine use in cell culture and therapy

Also Published As

Publication number Publication date
AU8500891A (en) 1992-02-04
DK0539525T3 (da) 2000-04-10
EP0539525B1 (en) 1999-10-27
JP3259960B2 (ja) 2002-02-25
DE69131752D1 (de) 1999-12-02
EP0539525A1 (en) 1993-05-05
WO1992000955A1 (en) 1992-01-23
GR3031801T3 (en) 2000-02-29
JPH06500106A (ja) 1994-01-06
AU655598B2 (en) 1995-01-05
EP0539525A4 (es) 1994-01-12
DE69131752T2 (de) 2000-06-29
HK1014367A1 (en) 1999-09-24
ATE186048T1 (de) 1999-11-15

Similar Documents

Publication Publication Date Title
BR9910251A (pt) Estimulação hematopoiética
ATE90345T1 (de) Bis-naphthalimide, ihre herstellung und verwendung.
AR009560A1 (es) Prolongacion de la sobrevida de injertos con porfirinas
MX9101913A (es) Derivados de quinazolinas para potenciar la actividad antitumoral
ZA975851B (en) Hepatocyte grown factor receptor agonists and uses thereof
ATE48844T1 (de) Heterocyclische verbindungen, ihre herstellung und verwendung.
DK1242578T3 (da) Celledyrkningsmedium indeholdende vækstfaktorer og L-glutamin
EA200400482A1 (ru) Кератиноциты, пригодные для применения в качестве биологически активной субстанции при лечении ран
ES2147780T3 (es) Compuestos sinteticos afines al extracto de corteza de roble, y procedimiento para utilizar los mismos.
EE9700225A (et) Meetod diabetes mellituse raviks, kasutades KKF
DE69535081D1 (de) Verwendung von Prostaglandin A oder dessen Derivaten zur Behandlung von Psoriasis
DE69200863D1 (de) Benzyloxyphenylderivate.
PT862452E (pt) Formulacao de estabilizacao para o ngf
DE69102651D1 (de) Proteaseresistenter pdgf und dessen verwendungen.
ES2139580T3 (es) Vitaleteina y su uso en el cultivo celular y en terapia.
DK0563256T3 (da) Anvendelse af værtscelle-phospholipider til inhibering af bakteriekolonisering
DK0538330T3 (da) Beta-Alethin-anvendelse til celledyrkning og terapi
ES2154290T3 (es) Estimulacion de la diferenciacion celular por sindecano.
ES471769A1 (es) Procedimiento para la obtencion de penicilinas
DE69021128D1 (de) Interleukin-1-Inhibitor.
MX170998B (es) Ligante hidraulico y procedimiento para su preparacion
DE69410492D1 (de) Isolierung und Struktur von Spongistatin 1 und dessen Verwendung als Antitumor-Mittel
ES2073636T3 (es) Procedimiento microbiologico para la preparacion de heterociclos hidroxilados.
ES2060233T3 (es) Streptomyces ncimb 40227 activo en la bioestimulacion de la produccion agricola.
ES2060050T3 (es) Beta-tioacrilamidas s-sustituidas y su uso como microbicidas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 539525

Country of ref document: ES